Weight-loss jab could be made for $3 a month, study finds
Cheap semaglutide, the drug in Ozempic and Wegovy, could help millions with diabetes and obesity in 160 countriesWeight-loss jabs such as Wegovy and Ozempic could be made for just $3 a month, according to new analysis, potentially making the treatment available to millions in poorer countries as...
<p>Cheap semaglutide, the drug in Ozempic and Wegovy, could help millions with diabetes and obesity in 160 countries</p><p>Weight-loss jabs such as Wegovy and Ozempic could be made for just $3 a month, according to new analysis, potentially making the treatment available to millions in poorer countries as patents expire.</p><p>More than <a href="https://www.theguardian.com/society/2024/feb/29/more-than-a-billion-people-worldwide-are-obese-research-finds">a billion people live with obesity</a> worldwide, with rates rising fast in lower-income nations as they <a href="https://www.theguardian.com/global-development/2025/sep/10/junk-food-upf-more-children-obese-than-underweight-unicef">shift to westernised diets</a> and more sedentary lifestyles.</p> <a href="https://www.theguardian.com/global-development/2026/mar/06/generic-drugs-weight-loss-semaglutide-ozempic-wegovy-diabetes-obesity-study">Continue reading...</a>
Read the full article at:
The Guardian World →